ID
13148
Description
Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00653250
Link
https://clinicaltrials.gov/show/NCT00653250
Keywords
Versions (1)
- 1/19/16 1/19/16 -
Uploaded on
January 19, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lung Cancer NCT00653250
Eligibility Lung Cancer NCT00653250
- StudyEvent: Eligibility
Similar models
Eligibility Lung Cancer NCT00653250
- StudyEvent: Eligibility
C0007131 (UMLS CUI [1,2])
C0010819 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C0006147 (UMLS CUI [2])
C0021441 (UMLS CUI [1,2])
C1522449 (UMLS CUI [1,2])